• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

2017-2023 年 COVID-19 大流行前后台湾儿童耐大环内酯类肺炎支原体感染。

Macrolide-Resistant Mycoplasma pneumoniae Infections among Children before and during COVID-19 Pandemic, Taiwan, 2017-2023.

出版信息

Emerg Infect Dis. 2024 Aug;30(8):1692-1696. doi: 10.3201/eid3008.231596.

DOI:10.3201/eid3008.231596
PMID:39043456
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11286047/
Abstract

Before the COVID-19 pandemic, Mycoplasma pneumoniae infections emerged during spring to summer yearly in Taiwan, but infections were few during the pandemic. M. pneumoniae macrolide resistance soared to 85.7% in 2020 but declined to 0% during 2022-2023. Continued molecular surveillance is necessary to monitor trends in macrolide-resistant M. pneumoniae.

摘要

在 COVID-19 大流行之前，台湾每年春季至夏季都会出现肺炎支原体感染，但大流行期间感染病例很少。2020 年肺炎支原体大环内酯类耐药率飙升至 85.7%，但在 2022-2023 年降至 0%。需要持续进行分子监测，以监测大环内酯类耐药肺炎支原体的趋势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a90/11286047/d24c95856df2/23-1596-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a90/11286047/b54094af1dbc/23-1596-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a90/11286047/d24c95856df2/23-1596-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a90/11286047/b54094af1dbc/23-1596-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a90/11286047/d24c95856df2/23-1596-F2.jpg

相似文献

1
Macrolide-Resistant Mycoplasma pneumoniae Infections among Children before and during COVID-19 Pandemic, Taiwan, 2017-2023.2017-2023 年 COVID-19 大流行前后台湾儿童耐大环内酯类肺炎支原体感染。
Emerg Infect Dis. 2024 Aug;30(8):1692-1696. doi: 10.3201/eid3008.231596.
2
Mycoplasma pneumoniae among Chinese Outpatient Children with Mild Respiratory Tract Infections during the Coronavirus Disease 2019 Pandemic.2019 年冠状病毒病大流行期间，中国门诊轻症呼吸道感染患儿中的肺炎支原体。
Microbiol Spectr. 2022 Feb 23;10(1):e0155021. doi: 10.1128/spectrum.01550-21. Epub 2022 Feb 9.
3
Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015.日本 2008-2015 年耐大环内酯类肺炎支原体感染。
Emerg Infect Dis. 2017 Oct;23(10):1703-1706. doi: 10.3201/eid2310.170106.
4
Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010-2011.2010-2011 年加拿大安大略省人类对大环内酯类药物耐药的肺炎支原体。
Emerg Infect Dis. 2013;19(9):1525-7. doi: 10.3201/eid1909.121466.
5
Macrolide-resistant Mycoplasma pneumoniae in children in Taiwan.台湾地区儿童中耐大环内酯类肺炎支原体。
J Infect Chemother. 2013 Aug;19(4):782-6. doi: 10.1007/s10156-012-0523-3. Epub 2012 Nov 30.
6
Emergence of Macrolide-Resistant Mycoplasma pneumoniae in Hong Kong Is Linked to Increasing Macrolide Resistance in Multilocus Variable-Number Tandem-Repeat Analysis Type 4-5-7-2.香港大环内酯类耐药肺炎支原体的出现与多位点可变数目串联重复序列分析4-5-7-2型中不断增加的大环内酯类耐药性有关。
J Clin Microbiol. 2015 Nov;53(11):3560-4. doi: 10.1128/JCM.01983-15. Epub 2015 Sep 2.
7
Severe macrolide-resistant Mycoplasma pneumoniae pneumonia associated with macrolide failure.与大环内酯类药物治疗失败相关的严重耐大环内酯类肺炎支原体肺炎
J Microbiol Immunol Infect. 2016 Feb;49(1):127-30. doi: 10.1016/j.jmii.2014.11.003. Epub 2014 Nov 11.
8
Multiple-locus variable-number tandem-repeat analysis (MLVA) of macrolide-susceptible and -resistant Mycoplasma pneumoniae in children in Taiwan.台湾地区儿童中对大环内酯类药物敏感和耐药的肺炎支原体的多位点可变数目串联重复分析（MLVA）。
J Formos Med Assoc. 2020 Oct;119(10):1539-1545. doi: 10.1016/j.jfma.2019.12.008. Epub 2020 Jan 8.
9
Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia.病毒混合感染和大环内酯类耐药支原体感染对难治性肺炎支原体肺炎患儿的影响。
BMC Infect Dis. 2020 Aug 26;20(1):633. doi: 10.1186/s12879-020-05356-1.
10
Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010.以色列 2010 年肺炎支原体大环内酯类耐药性。
Emerg Infect Dis. 2011 Jun;17(6):1079-82. doi: 10.3201/eid/1706.101558.

引用本文的文献

1
Clinical Manifestations, Macrolide Resistance, and Treatment Utilization Trends of Pneumonia in Children and Adolescents in South Korea.韩国儿童和青少年肺炎的临床表现、大环内酯类耐药性及治疗利用趋势
Microorganisms. 2024 Aug 31;12(9):1806. doi: 10.3390/microorganisms12091806.

本文引用的文献

1
Global Trends in the Proportion of Macrolide-Resistant Mycoplasma pneumoniae Infections: A Systematic Review and Meta-analysis.全球大环内酯类耐药肺炎支原体感染比例的趋势：系统评价和荟萃分析。
JAMA Netw Open. 2022 Jul 1;5(7):e2220949. doi: 10.1001/jamanetworkopen.2022.20949.
2
detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021.2017 年至 2021 年全球调查：COVID-19 大流行前后的检测结果。
Euro Surveill. 2022 May;27(19). doi: 10.2807/1560-7917.ES.2022.27.19.2100746.
3
The epidemiology, clinical characteristics, and macrolide susceptibility of Mycoplasma pneumoniae pneumonia in children in Southern Taiwan, 2019-2020.
2019-2020 年台湾南部儿童肺炎支原体肺炎的流行病学、临床特征和大环内酯类药物敏感性。
J Microbiol Immunol Infect. 2022 Aug;55(4):611-619. doi: 10.1016/j.jmii.2021.09.010. Epub 2021 Oct 13.
4
Persistent high macrolide resistance rate and increase of macrolide-resistant ST14 strains among Mycoplasma pneumoniae in South Korea, 2019-2020.2019-2020 年韩国肺炎支原体中大环内酯类药物持续高耐药率和大环内酯类耐药 ST14 株的增加。
J Microbiol Immunol Infect. 2022 Oct;55(5):910-916. doi: 10.1016/j.jmii.2021.07.011. Epub 2021 Aug 26.
5
Systematic review of empirical studies comparing the effectiveness of non-pharmaceutical interventions against COVID-19.系统评价比较非药物干预措施防治 COVID-19 有效性的实证研究。
J Infect. 2021 Sep;83(3):281-293. doi: 10.1016/j.jinf.2021.06.018. Epub 2021 Jun 20.
6
Clonal spread of macrolide-resistant Mycoplasma pneumoniae sequence type-3 and type-17 with recombination on non-P1 adhesin among children in Taiwan.台湾地区儿童中具有黏附素非 P1 区重组的大环内酯类耐药肺炎支原体 3 型和 17 型的克隆传播。
Clin Microbiol Infect. 2021 Aug;27(8):1169.e1-1169.e6. doi: 10.1016/j.cmi.2020.09.035. Epub 2020 Sep 30.
7
Sequence Type Changes Associated with Decreasing Macrolide-Resistant Mycoplasma pneumoniae, Japan.序列类型变化与大环内酯类耐药肺炎支原体减少相关，日本。
Emerg Infect Dis. 2020 Sep;26(9):2210-2213. doi: 10.3201/eid2609.191575.
8
Antimicrobial susceptibility and molecular characteristics of isolates across different regions of China.中国不同地区分离株的抗菌药物敏感性和分子特征。
Antimicrob Resist Infect Control. 2019 Aug 23;8:143. doi: 10.1186/s13756-019-0576-5. eCollection 2019.
9
Mycoplasma pneumoniae: Current Knowledge on Macrolide Resistance and Treatment.肺炎支原体：关于大环内酯类耐药性与治疗的当前认知
Front Microbiol. 2016 Jun 22;7:974. doi: 10.3389/fmicb.2016.00974. eCollection 2016.
10
Development of a Multilocus Sequence Typing Scheme for Molecular Typing of Mycoplasma pneumoniae.用于肺炎支原体分子分型的多位点序列分型方案的开发
J Clin Microbiol. 2015 Oct;53(10):3195-203. doi: 10.1128/JCM.01301-15. Epub 2015 Jul 22.